SCHEMBL22928325

SCHEMBL22928325

Cc1ccc(N(c2ccc(C)cc2)c2ccccc2-c2ccc3c(c2)-c2cc(-c4ccccc4N(c4ccc(C)cc4)c4ccc(C)cc4)ccc2S32(=O)c3ccc(-c4ccccc4N(c4ccc(C)cc4)c4ccc(C)cc4)cc3-c3cc(-c4ccccc4N(c4ccc(C)cc4)c4ccc(C)cc4)ccc32)cc1

nearest known ligand 0.32

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PTPRC P08575 1/20 0.32
▸ HPRT1 P00492 1/20 0.32
▸ PTAFR P25105 1/20 0.32
▸ RAB9A P51151 3/20 0.31
▸ NPC1 O15118 2/20 0.31
▸ HPGDS O60760 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ AGTR1 P30556 1/20 0.31
▸ CES1 P23141 1/20 0.31
▸ MEN1 O00255 3/20 0.31
▸ KMT2A Q03164 3/20 0.31
▸ POLB P06746 1/20 0.31
▸ APP P05067 1/20 0.30
▸ LTB4R2 Q9NPC1 1/20 0.30
▸ GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22928711 0.86 METAP2 (0.30) —
SCHEMBL22928311 0.85 ABL1 (0.40) PTAFRRAB9ANPC1TP53PKM
SCHEMBL22928716 0.83 ABL1 (0.38) PTAFRRAB9ANPC1TP53PKM
SCHEMBL22928408 0.83 PTAFR (0.33) PTAFRRAB9ANPC1MEN1KMT2A
SCHEMBL22928326 0.83 ABL1 (0.38) PTAFRRAB9ANPC1TP53PKM
SCHEMBL31191915 0.80 RAB9A (0.39) PTPRCHPRT1PTAFRRAB9ANPC1
SCHEMBL2258241 0.78 MEN1 (0.38) PTPRCHPRT1PTAFRRAB9ANPC1
SCHEMBL26401560 0.78 LTB4R2 (0.39) RAB9AMEN1KMT2ALTB4R2
SCHEMBL22928357 0.77 C5AR1 (0.34) PTPRCMAPK1CES1
SCHEMBL26401549 0.77 MEN1 (0.31) RAB9ANPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780831-B2 Compound, display panel and display apparatus Shanghai Tianma AM-OLED Co., Ltd. (CN) 2023-10-10 — — US disclosed
US-11780831-B2 Compound, display panel and display apparatus Shanghai Tianma AM-OLED Co., Ltd. (CN) 2023-10-10 — — US disclosed
US-20210024511-A1 COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS Shanghai Tianma AM-OLED Co., Ltd. (CN) 2021-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024511-A1 COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS C1S, DRD1, DRD3 PTPRC 3348/4885HPRT1 3392/4885PTAFR 4374/4885
US-11780831-B2 Compound, display panel and display apparatus C1S, DRD1, DRD3 PTPRC 3348/4885HPRT1 3392/4885PTAFR 4374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback